The Light Chain Defines the Duration of Action of Botulinum Toxin Serotype A Subtypes
ABSTRACT Botulinum neurotoxin (BoNT) is the causative agent of botulism and a widely used pharmaceutical to treat a variety of neurological diseases. BoNTs are 150-kDa protein toxins organized into heavy chain (HC) and light chain (LC) domains linked by a disulfide bond. The HC selectively binds to...
Guardado en:
Autores principales: | Sabine Pellett, Marite Bradshaw, William H. Tepp, Christina L. Pier, Regina C. M. Whitemarsh, Chen Chen, Joseph T. Barbieri, Eric A. Johnson |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
American Society for Microbiology
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/aedc52e97f8748b7906c9ad8d9dcb24e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Isolation and Characterization of the Novel Botulinum Neurotoxin A Subtype 6
por: Molly S. Moritz, et al.
Publicado: (2018) -
Purification and Characterization of Botulinum Neurotoxin FA from a Genetically Modified <named-content content-type="genus-species">Clostridium botulinum</named-content> Strain
por: Sabine Pellett, et al.
Publicado: (2016) -
New trends in botulinum toxin use in dermatology
por: Stefania Guida, et al.
Publicado: (2018) -
Ultrasonographic Evaluation of Three Approaches for Botulinum Toxin Injection into Tibialis Posterior Muscle in Chronic Stroke Patients with Equinovarus Foot: An Observational Study
por: Stefania Spina, et al.
Publicado: (2021) -
Clostridial Neurotoxins: Structure, Function and Implications to Other Bacterial Toxins
por: Shuowei Cai, et al.
Publicado: (2021)